CISTANE Trademark

Trademark Overview


On Saturday, November 12, 2022, a trademark application was filed for CISTANE with the United States Patent and Trademark Office. The USPTO has given the CISTANE trademark a serial number of 97674914. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 24, 2023. This trademark is owned by Pet Health Pharma, LLC. The CISTANE trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations
cistane

General Information


Serial Number97674914
Word MarkCISTANE
Filing DateSaturday, November 12, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, October 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOphthalmic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 4, 2022
Primary Code005
First Use Anywhere DateSaturday, November 12, 2022
First Use In Commerce DateSaturday, November 12, 2022

Trademark Owner History


Party NamePet Health Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFresno, CA 93720

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, October 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, October 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 5, 2023NON-FINAL ACTION E-MAILED
Monday, June 5, 2023NON-FINAL ACTION WRITTEN
Friday, June 2, 2023ASSIGNED TO EXAMINER
Sunday, December 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 16, 2022NEW APPLICATION ENTERED

Related Keywords


cistane preparations ophthalmic